Viread and Movicol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viread (tenofovir disoproxil fumarate) and Movicol (polyethylene glycol 3350). Common drug interactions include chronic kidney disease among females and spinal cord infection among males.

The phase IV clinical study analyzes what interactions people have when they take Viread and Movicol. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

12 people who take Viread and Movicol together, and have interactions are studied.

Viread and Movicol drug interactions.

What are the common drug interactions of Viread and Movicol, by gender? *:

female:

  1. Chronic kidney disease
  2. Hepatocellular carcinoma (liver cancer)
  3. Metastases to spine (cancer spreads to spine)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Anaphylactic reaction (serious allergic reaction)
  7. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)

male:

  1. Spinal cord infection
  2. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  3. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  4. Plasma cell myeloma (cancer that begins in plasma cells)
  5. Blood creatine phosphokinase increased
  6. Cytomegalovirus infection
  7. Disease progression
  8. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)

What are the common drug interactions of Viread and Movicol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  3. Hepatocellular carcinoma (liver cancer)
  4. Metastases to spine (cancer spreads to spine)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Blood creatine phosphokinase increased

60+:

  1. Spinal cord infection
  2. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  3. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  4. Plasma cell myeloma (cancer that begins in plasma cells)
  5. Anaphylactic reaction (serious allergic reaction)
  6. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  7. Cytomegalovirus infection
  8. Disease progression
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 5 people, 41.67%
  2. Anal Cancer: 2 people, 16.67%
  3. Transplant Rejection (a transplant material is not worked): 1 person, 8.33%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
  5. Psychotic Disorder: 1 person, 8.33%
  6. Pain: 1 person, 8.33%
  7. Nausea (feeling of having an urge to vomit): 1 person, 8.33%
  8. Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 1 person, 8.33%
  9. High Blood Pressure: 1 person, 8.33%
  10. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Viread and Movicol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Viread and Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viread and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Movicol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate and polyethylene glycol 3350 (the active ingredients of Viread and Movicol, respectively), and Viread and Movicol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: